Induction of carcinoembryonic-antigen-gene expression in human colorectal carcinoma by sodium butyrate

Biochem J. 1990 Dec 1;272(2):541-4. doi: 10.1042/bj2720541.

Abstract

The effect of sodium butyrate on the expression of the carcinoembryonic-antigen (CEA) gene was studied in two poorly differentiated colorectal-carcinoma cell lines (Clone-A and MIP-101) and in one well-differentiated cell line (LS-174T); A.T.C.C. no. CCL 188). Northern-blot and dot-blot analyses indicated a steady increase in CEA mRNA from day 4 to a maximal level by day 14 after these cells were exposed to 2 mM-sodium butyrate. Studies using nuclear run-off assays followed by dot-blot hybridization to a partial CEA cDNA clone demonstrated that specific increases in gene transcription rates (3-fold in MIP-101, 4-fold in LS-174T and 6-fold in Clone-A) are not sufficient to account for the observed increases in CEA mRNA abundance. Further studies showed that CEA-specific transcripts have a half-life of about 60-80 min, and treatment with sodium butyrate increased the stability of CEA-specific transcripts to about 340 min in LS-174T cells and to about 500 min in Clone-A cells. We conclude that the induction of the CEA-gene expression by sodium butyrate in colorectal-cancer cells is mediated by both transcriptional and post-transcriptional mechanisms, with CEA mRNA stability as one of the major check-points.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Butyrates / pharmacology*
  • Butyric Acid
  • Carcinoembryonic Antigen / genetics*
  • Cell Differentiation
  • Cell Line
  • Cell Nucleus / metabolism
  • Cloning, Molecular
  • Colorectal Neoplasms
  • DNA, Neoplasm / genetics
  • Gene Expression Regulation, Neoplastic / drug effects*
  • Humans
  • Kinetics
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Transcription, Genetic / drug effects

Substances

  • Butyrates
  • Carcinoembryonic Antigen
  • DNA, Neoplasm
  • RNA, Messenger
  • Butyric Acid